Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $1,632 - $4,380
1,200 New
1,200 $1,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $56,715 - $98,420
-9,500 Reduced 7.1%
124,300 $1.22 Million
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $291,342 - $493,122
-35,400 Reduced 20.92%
133,800 $1.12 Million
Q2 2023

Aug 14, 2023

SELL
$9.97 - $14.05 $122,631 - $172,815
-12,300 Reduced 6.78%
169,200 $2.25 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $265,196 - $401,468
33,400 Added 22.55%
181,500 $2.1 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $426,951 - $843,360
75,300 Added 103.43%
148,100 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $78,207 - $170,543
19,900 Added 37.62%
72,800 $423,000
Q2 2022

Aug 08, 2022

SELL
$4.02 - $10.43 $19,295 - $50,064
-4,800 Reduced 8.32%
52,900 $234,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $424,872 - $1.05 Million
50,400 Added 690.41%
57,700 $525,000
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $620,172 - $968,576
-32,200 Reduced 81.52%
7,300 $149,000
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $340,582 - $479,774
13,700 Added 53.1%
39,500 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $336,730 - $543,902
15,100 Added 141.12%
25,800 $902,000
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $100,244 - $194,370
-3,800 Reduced 26.21%
10,700 $356,000
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $15,750 - $42,750
1,500 Added 11.54%
14,500 $376,000
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $26,714 - $73,038
7,400 Added 132.14%
13,000 $128,000
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $42,665 - $64,883
-16,100 Reduced 74.19%
5,600 $19,000
Q1 2020

May 15, 2020

BUY
$2.36 - $5.26 $51,212 - $114,142
21,700 New
21,700 $66,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.